[
1. Spasic B.Why Serbs are disappearing?. 9. edition. Kragujevac: Printing house Skver. 2009. pp 39-41.
]Search in Google Scholar
[
2. Institute of Public Health of Serbia “dr Milan Јovanovic Batut”. Health statistical yearbook of Republic of Serbia for 2010. year. Belegrade: Available at http://www.batut.org.rs/download/aktuelno, Last visited: 10.04.2020.
]Search in Google Scholar
[
3. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev 2011. 10(4):430-439.10.1016/j.arr.2011.03.00321402176
]Search in Google Scholar
[
4. Nezić L.Clinical pharmacology in geriatrics. Medical Faculty of Banja Luka. 2018. pp: 20-1
]Search in Google Scholar
[
5. Janković MS. Pharmacology and Toxicology. Medical Faculty Kragujevac, 2011. pp: 59-60.
]Search in Google Scholar
[
6. Louis-Simonet M, Kossovsky MP, Sarasin FP, Chopard P, Gabriel V, Perneger TV, et al. Effects of a structured patient-centered discharge interview on patients’ knowledge about their medications. Am J Med 2004; 117(8):563-56810.1016/j.amjmed.2004.03.03615465504
]Search in Google Scholar
[
7. Galvin R, Moriarty F, Cousins G, Cahir C, Motterlini N, Bradley M, et al. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol 2014; 70(5):599–606.10.1007/s00228-014-1651-8397837824493365
]Search in Google Scholar
[
8. Oxford academic. Age and Ageing. STOPP and START criteria 2015. Available at: https://www.farmaka.be/frontend/files/publications/files/liste-stopp-startversion-2.pdf? Last visited: 19. 12. 2020.
]Search in Google Scholar
[
9. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Beh Res Methods 2007; 39(2):175–191.10.3758/BF0319314617695343
]Search in Google Scholar
[
10. Kovačević VS., Simišić M., Stojkov RS., et al. Potentially Inappropriate Prescribing in Older Primary Care Patients. 2014. 9: 4 (e95536).10.1371/journal.pone.0095536399903524763332
]Search in Google Scholar
[
11. Xhyljeta Luta, Christophe Bagnoud, Mark Lambiris et al. Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data. BMJ Open. 2020. 10(1): e031156.10.1136/bmjopen-2019-031156695549831911512
]Search in Google Scholar
[
12. Donovan T. Maust, Frederic C. Blow, Ilse R. Wiechers, Helen C. Kales, Steven C. Marcus. National trends in antidepressant, benzodiazepine, and other sedativehypnotic treatment of older adults in psychiatric and primary Care. J Clin Psychiatry. 2017. 78(4): e363-e371.10.4088/JCP.16m10713540845828448697
]Search in Google Scholar
[
13. Leo A Coleman, Jonathan Brett, Benjamin J Daniels, Michael O Falster. Medicine reviews: do they reduce benzodiazepine use in older Australians? 2021. 8;31(3):30452015.10.17061/phrp3045201534494072
]Search in Google Scholar
[
14. Xiao-Mei Zhong, Fei Wang, Qinge Zhang et al. Concurrent benzodiazepine use in older adults treated with antidepressants in Asia. 2019. 31(5):685-691.10.1017/S104161021700256329212560
]Search in Google Scholar
[
15. Rebecca Hedrick, Samuel Korouri, Emile Tadros et al. The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure. Drugs in Context 2020. 9: 2020-5-4.10.7573/dic.2020-5-4739861632788920
]Search in Google Scholar
[
16. Bianca Kollhorst,,Kathrin Jobski, Jutta Krappweis, Tania Schink,, Edeltraut Garbe, Niklas Schmedt. Antidepressants and the risk of death in older patients with depression: A population-based cohort study. 2019. PLoS ONE 14(4): e0215289.10.1371/journal.pone.0215289646418730986235
]Search in Google Scholar
[
17. Projovic I., Vukadinovic D., Milovanovic O., et al. Risk factors for potentially inappropriate prescribing to older patients in primary care. Eur J Clin Pharmacol. 2016. 72(1):93-107.10.1007/s00228-015-1957-126416101
]Search in Google Scholar
[
18. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry A. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med 2010. 7(10):e1000352.10.1371/journal.pmed.1000352295739420976098
]Search in Google Scholar
[
19. Iria Fernández-Álvarez, Maruxa Zapata-Cachafeiro, Juan Vázquez-Lago et al. Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care. PLoS One. 2019. 22;14(8):e0221326.10.1371/journal.pone.0221326670605731437201
]Search in Google Scholar
[
20. Samardžić J., Zeković J., Stevanović A., Jančić j., Dimitrijević I. Benzodiazepine (ab)use and addictive potential: Analyses of consumption in Serbia for the period 2014–2016. Engrami. 2018.40: (2).10.5937/Engrami1802073S
]Search in Google Scholar
[
21. Balon R., Chouinard G., Cosci F., et al. International Task Force on Benzodiazepines. Psychother Psychosom 2018. 87(4):193-94.10.1159/00048953829788029
]Search in Google Scholar
